Newswise — The National Inhalant Prevention Coalition, with support from the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA), will hold a press conference March 17 to discuss disturbing new government data about the public health problem of inhalant abuse by adults. The event will feature:
WHO: H. Westley Clark, M.D., M.P.H., Director, Center for Substance Abuse Treatment, SAMHSA
Gil Kerlikowske, Director, Office of National Drug Control Policy
Harvey Weiss, Executive Director, National Inhalant Prevention Coalition
David Shurtleff, Ph.D., Acting Deputy Director, National Institute on Drug Abuse, NIH
Howard C. Wolfe, MA, LMFT, an inhalant expert and director of the New England Inhalant Abuse Coalition
Jennifer N. Caudle, D.O., an osteopathic family physician from Ypsilanti, Michigan, representing the American Osteopathic Association.
Erin Davis, a 42 year-old woman in recovery from addiction to inhalants, from Centerville, Ohio, outside of Dayton.
WHEN: March 17, 2011 at 9:30 A.M.
WHERE: National Press Club
Holman Lounge
14th and F Streets, NW
Washington, D.C.
Metro: Metro Center
SAMHSA is a public health agency within the Department of Health and Human Services. Its mission is to reduce the impact of substance abuse and mental illness on America’s communities.